secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2026-06-12T20:05:45+00:00
Accession:  0001801170-26-000148
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Clover Health shareholders elect directors, approve say-on-pay, ratify E&Y at 2026 meeting
--------------------------------------------------------------------------------

- Demetrios L. Kouzoukas, Andrew Toy, Thomas L. Tran elected as Class II directors until 2029.
- Non-binding advisory vote on 2025 NEO compensation approved with ~1.00B votes for, ~9.8M against.
- Ratification of Ernst & Young as independent auditor for FY2026 approved with ~1.19B votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117026000148/0001801170-26-000148-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117026000148/clov-20260610.htm
  HTML page:      https://secwatch.observer/filing/0001801170-26-000148

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer